What is the Org number of Orifarm Generics AB?

Orifarm Generics AB is registered with Bolagsverket / SCB under Org 5566228937.

What is the revenue of Orifarm Generics AB?

Orifarm Generics AB reported revenue of SEK 714,3M in 2024.

Who is the CEO of Orifarm Generics AB?

Lovisa Gertrud Cecilia Dahl Nelson is Authorized Recipient of Service of Orifarm Generics AB, in role since 2022.

Who is the chairman of Orifarm Generics AB?

Hans Bögh-Sörensen chairs the board of Orifarm Generics AB, in role since 2022.

Where is Orifarm Generics AB headquartered?

Orifarm Generics AB's registered address is Klara Södra Kyrkogata 1.

Orifarm Generics AB

ABActive

Org 5566228937Klara Södra Kyrkogata 1, 111 52 StockholmWholesale of pharmaceutical and medical goods · NACE 4646Est. 200210-19 employees

Overview Financials People & ownership Related companies

Financials

RevenueSEK millions

EBITDASEK millions

Income statementSEK thousands

Item	2020	2021	2022	2023	2024
Revenue	332 397	495 016	487 758	579 343	714 283
Staff expenses	—	—	—	—	—
EBITDA	2 987	12 330	8 536	10 139	14 286
Depreciation & amort.	−0	−0	−0	−0	−0
EBIT	2 987	12 330	8 536	10 139	14 286
Net financials	−1 279	−681	4 166	1 157	708
Profit before tax	2 121	11 884	12 755	11 330	15 013
Tax	−460	−2 459	−2 691	−2 758	−2 685
Net profit	1 661	9 425	10 064	8 572	12 328

Balance sheetSEK thousands

Item	2020	2021	2022	2023	2024
Total assets	45 898	79 919	110 637	150 322	129 478
Equity	9 418	18 843	28 906	30 779	31 906
Long-term debt	0	0	0	0	0
Short-term debt	36 480	61 076	81 731	119 543	97 572
Total debt	36 480	61 076	81 731	119 543	97 572

Financial ratios5-year trend

EBITDA margin

2.0%

This company

15.8%

Market median

-87% vs market

20202024

Equity ratio

24.6%

This company

38.2%

Market median

-36% vs market

20202024

Return on equity

38.6%

This company

18.4%

Market median

+110% vs market

20202024

Net profit margin

1.7%

This company

8.1%

Market median

-79% vs market

20202024

Asset turnover

5.52×

This company

1.12×

Market median

+393% vs market

20202024

Debt / equity

3.06×

This company

0.62×

Market median

-394% vs market

20202024

Annual reports & filings

Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31